Search

Log-In

Log-in to eBloodBank

Why Register?

Registering with Chiron.com is for Chiron customers, partners and distributors only.

Contact Us

ISBT 2005 Athens Abstracts

Adobe Acrobat required for viewing Abstracts. Download it free here.

To save an abstract, right click, and choose "Save Target As".

Earlier detection of human immunodeficiency type 1, hepatitis C and hepatitis B viruses using the PROCLEIX ULTRIO assay on the PROCLEIX^® System and PROCLEIX^® TIGRIS^® System compared to serology
First Months of using PROCLEIX^® ULTRIO^® nulceic acid testing (NAT) assay
Hepatitis B in blood donors: relation between HBV-DNA viral load and other serological markers
Hepatitis B residual risk in Transfusion
Look back studies of anti-HCV negative/HCV RNA positive blood donors identified low viremic donation not detected by mini-pool NAT
NAT screening for HCV HIV HBV in blood donors. Analytical evaluation and management one year after implementation with Chiron PROCLEIX ULTRIO
Preliminary results of mini-pool and single doantaion HBV-DNA screening in Poland
Quality control program for nucleic acid screening in blood service laboratories
Results from the PROCLEIX^® HIV-1/HCV and HIV-1/HCV/HBV (PROCLEIX ULTRIO) assays for the detection of HIV-1 RNA, HCV RNA and HBV DNA in blood donors of two blood transfusion centers of SW Greece
Should HBV NAT be implemented in French blood donors?
Two years' experience of nucleic acid technology (NAT) screening of single donations for HIV 1 RNA/RNA and HIV 1 RNA/HCV-RNA/HBV DNA